Considerations for radiotherapy planning with MV photons using dose-to-medium

使用剂量介质进行MV光子放射治疗计划的注意事项

阅读:3

Abstract

BACKGROUND AND PURPOSE: Radiotherapy planning considerations were developed for the previous calculation algorithms yielding dose to water-in-water (D(w,w)). Advanced algorithms improve accuracy, but their dose values in terms of dose to medium-in-medium (D(m,m)) depend on the medium considered. This work aimed to show how mimicking D(w,w) planning with D(m,m) can introduce new issues. MATERIALS AND METHODS: A head and neck case involving bone and metal heterogeneities outside the CTV was considered. Two different commercial algorithms were used to obtain D(m,m) and D(w,w) distributions. First, a plan was optimised to irradiate the PTV uniformly and get a homogeneous D(w,w) distribution. Second, another plan was optimised to achieve homogeneous D(m,m). Both plans were calculated with D(w,w) and D(m,m), and the differences between their dose distributions, clinical impact, and robustness were evaluated. RESULTS: Uniform irradiation produced D(m,m) cold spots in bone (-4%) and implants (-10%). Uniform D(m,m) compensated them by increasing fluence but, when recalculated in D(w,w), the fluence compensations produced higher doses that affected homogeneity. Additionally, doses were 1% higher for the target, and + 4% for the mandible, thus increasing toxicity risk. Robustness was impaired when increased fluence regions and heterogeneities mismatched. CONCLUSION: Planning with D(m,m) as with D(w,w) can impact clinical outcome and impair robustness. In optimisation, uniform irradiation instead of homogeneous D(m,m) distributions should be pursued when media with different D(m,m) responses are involved. However, this requires adapting evaluation criteria or avoiding medium effects. Regardless of the approach, there can be systematic differences in dose prescription and constraints.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。